FY2024 EPS Estimates for AnaptysBio Lifted by HC Wainwright

AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Research analysts at HC Wainwright increased their FY2024 earnings estimates for shares of AnaptysBio in a report released on Wednesday, December 11th. HC Wainwright analyst E. Bodnar now forecasts that the biotechnology company will post earnings per share of ($6.09) for the year, up from their prior estimate […]

Leave a Reply

Your email address will not be published.

Previous post Zacks Research Increases Earnings Estimates for Novartis
Next post Slate Office REIT (TSE:SOT.UN) Trading 1.3% Higher – Should You Buy?